These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Design and synthesis of nonsteroidal progesterone receptor antagonists based on C,C'-diphenylcarborane scaffold as a hydrophobic pharmacophore. Fujii S; Yamada A; Nakano E; Takeuchi Y; Mori S; Masuno H; Kagechika H Eur J Med Chem; 2014 Sep; 84():264-77. PubMed ID: 25036787 [TBL] [Abstract][Full Text] [Related]
44. Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. Endo Y; Iijima T; Yamakoshi Y; Yamaguchi M; Fukasawa H; Shudo K J Med Chem; 1999 May; 42(9):1501-4. PubMed ID: 10229620 [No Abstract] [Full Text] [Related]
45. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer. Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261 [TBL] [Abstract][Full Text] [Related]
46. Novel retinoid X receptor (RXR) antagonists having a dicarba-closo-dodecaborane as a hydrophobic moiety. Ohta K; Iijima T; Kawachi E; Kagechika H; Endo Y Bioorg Med Chem Lett; 2004 Dec; 14(23):5913-8. PubMed ID: 15501068 [TBL] [Abstract][Full Text] [Related]
47. Estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. Endo Y; Yoshimi T; Iijima T; Yamakoshi Y Bioorg Med Chem Lett; 1999 Dec; 9(24):3387-92. PubMed ID: 10617077 [TBL] [Abstract][Full Text] [Related]
48. Suppression of mutant androgen receptors by flutamide. Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135 [TBL] [Abstract][Full Text] [Related]
49. Chemical synthesis and biological activities of 16alpha-derivatives of 5alpha-androstane-3alpha,17beta-diol as antiandrogens. Roy J; Breton R; Martel C; Labrie F; Poirier D Bioorg Med Chem; 2007 Apr; 15(8):3003-18. PubMed ID: 17336533 [TBL] [Abstract][Full Text] [Related]
50. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523 [TBL] [Abstract][Full Text] [Related]
51. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones. Higuchi RI; Arienti KL; López FJ; Mani NS; Mais DE; Caferro TR; Long YO; Jones TK; Edwards JP; Zhi L; Schrader WT; Negro-Vilar A; Marschke KB J Med Chem; 2007 May; 50(10):2486-96. PubMed ID: 17439112 [TBL] [Abstract][Full Text] [Related]
52. Synthesis of monosubstituted functional derivatives of carboranes from 1-mercapto-ortho-carborane: 1-HOOC(CH(2))(n)S-1,2-C(2)B(10)H(11) and [7-HOOC(CH(2))(n)S-7,8-C(2)B(9)H(11)](-) (n = 1-4). Stogniy MY; Sivaev IB; Petrovskii PV; Bregadze VI Dalton Trans; 2010 Feb; 39(7):1817-22. PubMed ID: 20449427 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related]
55. Establishment of a novel immortalized human prostatic epithelial cell line stably expressing androgen receptor and its application for the functional screening of androgen receptor modulators. Yu S; Wang MW; Yao X; Chan FL Biochem Biophys Res Commun; 2009 May; 382(4):756-61. PubMed ID: 19324023 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor. Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333 [TBL] [Abstract][Full Text] [Related]
57. Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones. van Oeveren A; Motamedi M; Martinborough E; Zhao S; Shen Y; West S; Chang W; Kallel A; Marschke KB; López FJ; Negro-Vilar A; Zhi L Bioorg Med Chem Lett; 2007 Mar; 17(6):1527-31. PubMed ID: 17267219 [TBL] [Abstract][Full Text] [Related]
58. Structure-activity relationships in carboxamide derivatives based on the targeted delivery of radionuclides and boron atoms by means of peripheral benzodiazepine receptor ligands. Cappelli A; Pericot Mohr Gl; Gallelli A; Giuliani G; Anzini M; Vomero S; Fresta M; Porcu P; Maciocco E; Concas A; Biggio G; Donati A J Med Chem; 2003 Aug; 46(17):3568-71. PubMed ID: 12904061 [TBL] [Abstract][Full Text] [Related]
59. Structural development of p-carborane-based potent non-secosteroidal vitamin D analogs. Fujii S; Sekine R; Kano A; Masuno H; Songkram C; Kawachi E; Hirano T; Tanatani A; Kagechika H Bioorg Med Chem; 2014 Nov; 22(21):5891-901. PubMed ID: 25284253 [TBL] [Abstract][Full Text] [Related]
60. Novel androgen receptor full antagonists: Design, synthesis, and a docking study of glycerol and aminoglycerol derivatives that contain p-carborane cages. Kaise A; Ohta K; Fujii S; Oda A; Goto T; Endo Y Bioorg Med Chem; 2018 Jul; 26(13):3805-3811. PubMed ID: 29903411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]